1812890-23-5(6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine)
1812890-23-5 Basic informationMore
- Product Name:6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
- Synonyms: 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Related Compound 23 5H-Pyrrolo[2,3-d]pyrimidin-4-amine, 6,7-dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]- Azilsartan medoxomil impurity319 Tofacitinib Hydrogenation Impurities (6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-methyl-(4-methyl-piperidin-3-yl)-amine Tofatinib Impurity 17 N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity)
- CAS:1812890-23-5
- MF:C13H21N5
- MW:247.34
- EINECS:
- Mol File:1812890-23-5.mol
-
Recommend You Select Member Companies
- Company Name:Standardpharm Co. Ltd.
- Tel:86-714-3992388
- Nationality:United States
- Products Intro:Product Name:Tofacitinib Impurity 51
CAS:1812890-23-5
Purity:0.99 Package:10mg;25mg;50mg;100mg - CB Index:58
- Related Information:Catalog(14332)